BioSpace News Archive

Genetown

Merus to Present at the H.C. Wainwright Global Investment Conference

Merus N.V. announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will present at the H.C. Wainwright Global Investment Conference.

May 17, 2022
·
1 min read
Business

QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update

QSAM Biosciences Inc . (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153 DOTMP (CycloSam ® ), for the treatment of bone cancer and related diseases, today announces financial results for the first quarter ended March 31, 2022.

May 17, 2022
·
11 min read
Biotech Beach

aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference

aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference.

May 17, 2022
·
8 min read
Genetown

Morphic Announces Participation in 2022 RBC Capital Markets Global Healthcare Conference

Morphic Therapeutic announced that members of its management team will participate in a fireside chat at the RBC Capital Markets on Wednesday, May 18that 8:00 AM ET.

May 17, 2022
·
1 min read
Pharm Country

Idera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC– Enrollment Stopped Early for Efficacy –

Idera Pharmaceuticals, Inc. (“Idera,” “we,” and “our”) (Nasdaq: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, regarding its investigator-sponsored trial, INTRIM 1, involving tilsotolimod, Idera’s synthetic Toll-like receptor 9 agonist.

May 17, 2022
·
8 min read
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range

Medtronic plc announced data showing the benefits of the Symplicity Blood Pressure Procedure with the Symplicity Spyral™ Renal Denervation system on achieving target blood pressure level ranges.

May 17, 2022
·
5 min read
Business

ABL AND ODIMMA THERAPEUTICS JOIN FORCES IN PERSONALIZED CANCER IMMUNOTHERAPY

ABL Europe ( ABL ) and Odimma Therapeutics announced that they have signed a development agreement.

May 17, 2022
·
3 min read
Business

Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis and inflammatory diseases reports financial results for the three months ended March 31, 2022.

May 17, 2022
·
8 min read
Business

Insmed To Present at the H.C. Wainwright Annual Global Life Sciences Conference

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the H.C. Wainwright Annual Global Life Sciences Conference.

May 17, 2022
·
1 min read
Genetown

Obsidian Therapeutics to Present Significant Advancements to its Proprietary cytoDRiVE® Technology at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2022

Obsidian Therapeutics to Present Significant Advancements to its Proprietary cytoDRiVE® Technology at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2022.

May 17, 2022
·
3 min read